Life

Health, science, climate, and society-focused reporting.

Briefing: Health AI startup to benefit from $1 billion funding round for Yann LeCun’s AMI

Strategic angle: AI scribe company Nabla aims to be much more by using tech from Yann LeCun's new startup AMI, which just raised $1 billion.

Editorial Staff Mar 10

Life

Briefing: U.S. Senator Probes FDA Amid BioNTech Founders' Departure

Strategic angle: The co-founders of BioNTech, known for their Covid-19 vaccine, are set to leave the company to launch a new mRNA-focused venture.

Editorial Staff Mar 10

Life

Briefing: Amid dueling autism meetings, HHS cancels

Strategic angle: Epilepsy med response, a long-awaited fix to the kidney transplant system, and more health news

Editorial Staff Mar 10

Life

Briefing: Oral Contraceptive Pills: Access and Availability

Strategic angle: An overview of oral contraception, insurance coverage, and strategies to enhance access for women.

Editorial Staff Mar 10

Life

Briefing: Large drugmakers are developing fewer antibiotics, analysis finds

Strategic angle: The number of potential antimicrobial treatments being developed by the world’s largest drugmakers nosedived by 35% over the past five years, according to a new analysis.

Editorial Staff Mar 10

Life

Briefing: Removing race from kidney function algorithm helped more Black patients access transplants

Strategic angle: A significant change in the eGFR algorithm led to increased kidney transplant opportunities for Black patients.

Editorial Staff Mar 10

Life

Briefing: Over-the-Counter Oral Contraceptive Pills Approved

Strategic angle: FDA approves Opill, marking a significant change in access to oral contraceptives in the U.S.

Editorial Staff Mar 10

Life

Briefing: Vertex says its drug successfully reduced marker of kidney disease in late-stage trial

Strategic angle: Vertex reported that its drug, acquired for $4.9 billion, halved a key marker of IgA nephropathy in late-stage trials.

Editorial Staff Mar 9

Life

Briefing: KFF Tracker: America First MOU Bilateral Global Health Agreements

Strategic angle: This tracker provides up-to-date information on countries with signed bilateral MOU global health agreements with the U.S.

Editorial Staff Mar 9

Life

Briefing: The ER Staffing Conflict and No Facility Fee for a Marmot

Strategic angle: A battle between doctors and a hospital system is an early test of a new law designed to separate business and medicine.

Editorial Staff Mar 9

Life

Briefing: Medicaid Waiver Tracker: Approved and Pending Section 1115 Waivers by State

Strategic angle: Tracking the status of Section 1115 Medicaid waivers across states, highlighting approved and pending provisions.

Editorial Staff Mar 9

Life

Briefing: A setback for Roche’s breast cancer drug

Strategic angle: Wall Street's verdict on Prasad, generic semaglutide's new pricing, and other biotech news

Editorial Staff Mar 9

Life

Briefing: Novo Nordisk, Hims reach deal to end bitter dispute over Wegovy sales

Strategic angle: Novo Nordisk and Hims & Hers have reached a deal that, for now, appears to end their bitter dispute around Hims’ sale of compounded versions of Novo’s blockbuster obesity drug.

Editorial Staff Mar 9

Life

Briefing: Fresh turmoil at the FDA with Prasad’s exit

Strategic angle: Prasad out again, generic Ozempic on its way, and more health news from Morning Rounds

Editorial Staff Mar 9

Life

Briefing: Lack of FDA Advisory Committees Raises Concerns

Strategic angle: Growing worries about the FDA's diminishing use of advisory committees for public discourse.

Editorial Staff Mar 9

Life

Briefing: Talkspace to be acquired for $835 million by mental health services giant

Strategic angle: Universal Health Services announces acquisition of virtual mental health company Talkspace.

Editorial Staff Mar 9

Life

Briefing: Xenon Pharmaceuticals’ seizure drug shows strong efficacy in late-stage trial

Strategic angle: Xenon Pharmaceuticals reported significant reduction in seizure frequency with its new treatment compared to placebo.

Editorial Staff Mar 9

Life

Briefing: Blue Cross Blue Shield says data back up claim that AI is driving up medical bills

Strategic angle: A new data analysis from Blue Cross Blue Shield shows how AI coding may be driving up the cost of health care.

Editorial Staff Mar 9

Life

Briefing: Health tech company says it will dive into Medicare’s new chronic care experiment

Strategic angle: How a remote patient monitoring company is reworking its tech to enroll in a Medicare program seeking to align payment with health care outcomes.

Editorial Staff Mar 9

Life

Briefing: Opinion: The financial reason why parents beg me to diagnose their kids with autism

Strategic angle: Parents often pressure Lawrence Diller, a behavioral/developmental pediatrician, to diagnose their children with autism. He thinks he knows why.

Editorial Staff Mar 9